← Back to headlines
Jim Cramer Urges Novo Nordisk to Compete with Eli Lilly in Market, Not Courts
Jim Cramer has expressed his desire for Novo Nordisk A/S (NYSE:NVO) to focus on market competition with Eli Lilly rather than engaging in legal battles.
25 Jul, 07:48 — 25 Jul, 07:48
Sources
Showing 1 of 1 sources
